Dyameo develops single-use endoscopic probes for the instant detection of cancer cells.
Dyameo has raised $3.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2026.
Dyameo's investors include Bpifrance, AQUITI Gestion, OBRATORI, Medevice, Estellior Capital.
Dyameo is headquartered in Limoges, France.
Dyameo develops single-use endoscopic probes for the instant detection of cancer cells.
Dyameo is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dyameo — Funding & Investors." VCBacked, October 22, 2026, https://www.vcbacked.co/company/dyameo. Accessed November 15, 2026.
VCBacked. (2026). Dyameo — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/dyameo
{{cite web |title=Dyameo — Funding & Investors |url=https://www.vcbacked.co/company/dyameo |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Dyameo? Request a listing update